TipRanks
Advertisement
Advertisement

VTRS Stock Latest News

Viatris announces FDA approval of ryzumvi for treatment of presbyopia in adults
The FlyViatris announces FDA approval of ryzumvi for treatment of presbyopia in adults
3d ago
VTRS
Opus Genetics reports FDA approval of phentolamine ophthalmic solution 0.75%
PremiumThe Fly
Opus Genetics reports FDA approval of phentolamine ophthalmic solution 0.75%
3d ago
IRD
VTRS
Pacira price target raised to $36.50 from $25 at RBC Capital
PremiumThe Fly
Pacira price target raised to $36.50 from $25 at RBC Capital
10d ago
PCRX
VTRS
Why Is Pacira Pharmaceuticals Stock (PCRX) Up 44% Today?
PremiumMarket News
Why Is Pacira Pharmaceuticals Stock (PCRX) Up 44% Today?
11d ago
PCRX
VTRS
Pacira upgraded to Neutral from Underweight at JPMorgan
PremiumThe Fly
Pacira upgraded to Neutral from Underweight at JPMorgan
11d ago
PCRX
VTRS
Viatris to Acquire Pacira, Expanding Non-Opioid Portfolio
PremiumCompany AnnouncementsViatris to Acquire Pacira, Expanding Non-Opioid Portfolio
11d ago
8K
VTRS
Viatris: Pacira deal expected to be immediately accretive to financial guidance
Premium
The Fly
Viatris: Pacira deal expected to be immediately accretive to financial guidance
11d ago
PCRX
VTRS
Viatris to acquire Pacira for $36.50 per share in cash, or $1.65B
Premium
The Fly
Viatris to acquire Pacira for $36.50 per share in cash, or $1.65B
11d ago
PCRX
VTRS
Viatris to acquire Pacira for $36.50 per share in cash, or $1.65B
PremiumThe Fly
Viatris to acquire Pacira for $36.50 per share in cash, or $1.65B
11d ago
PCRX
VTRS
Viatris price target raised to $26 from $23 at UBS
PremiumThe Fly
Viatris price target raised to $26 from $23 at UBS
14d ago
VTRS
Viatris initiated with an Outperform at Oppenheimer
PremiumThe Fly
Viatris initiated with an Outperform at Oppenheimer
26d ago
VTRS
Viatris announces approval for Wakix in Japan
PremiumThe Fly
Viatris announces approval for Wakix in Japan
1M ago
VTRS
Viatris price target raised to $13 from $12 at Piper Sandler
PremiumThe FlyViatris price target raised to $13 from $12 at Piper Sandler
1M ago
VTRS
Leerink sees growth for Viatris, starts at Outperform
Premium
The Fly
Leerink sees growth for Viatris, starts at Outperform
1M ago
VTRS
Viatris initiated with an Outperform at Leerink
Premium
The Fly
Viatris initiated with an Outperform at Leerink
1M ago
VTRS
Viatris price target raised to $20 from $15 at Argus
PremiumThe Fly
Viatris price target raised to $20 from $15 at Argus
1M ago
VTRS
Einhorn’s DME Capital buys Fortune Brands, exits Peloton in Q2
PremiumThe Fly
Einhorn’s DME Capital buys Fortune Brands, exits Peloton in Q2
2M ago
AR
BHF
Viatris Earnings Call: Guidance Raised Amid Headwinds
PremiumCompany Announcements
Viatris Earnings Call: Guidance Raised Amid Headwinds
2M ago
VTRS
Harrow to acquire global rights to Tyrvaya from Viatris for up to $100M
PremiumThe Fly
Harrow to acquire global rights to Tyrvaya from Viatris for up to $100M
2M ago
HROW
VTRS
Viatris Lifts 2026 Outlook After Strong Second Quarter
PremiumCompany AnnouncementsViatris Lifts 2026 Outlook After Strong Second Quarter
2M ago
8K
VTRS
Viatris reports Q2 adjusted EPS 69c, consensus 60c
Premium
The Fly
Viatris reports Q2 adjusted EPS 69c, consensus 60c
2M ago
VTRS
Viatris raises FY26 adjusted EPS view to $2.45-$2.59 from $2.33-$2.47
Premium
The Fly
Viatris raises FY26 adjusted EPS view to $2.45-$2.59 from $2.33-$2.47
2M ago
VTRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >